Schonfeld Strategic Advisors LLC Alkermes Plc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 149,882 shares of ALKS stock, worth $4.73 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
149,882
Holding current value
$4.73 Million
% of portfolio
0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$23.01 - $28.55 $3.45 Million - $4.28 Million
149,882 New
149,882 $4.2 Million
Q1 2023

May 15, 2023
BUY
$25.31 - $29.02 $1.16 Million - $1.32 Million
45,654 Added 31.02%
192,842 $5.44 Million
Q4 2022

Feb 14, 2023
SELL
$21.94 - $26.24 $1.9 Million - $2.28 Million
-86,723 Reduced 37.08%
147,188 $3.85 Million
Q3 2022

Nov 14, 2022
SELL
$22.0 - $31.87 $2.28 Million - $3.3 Million
-103,697 Reduced 30.72%
233,911 $5.22 Million
Q2 2022

Aug 15, 2022
BUY
$26.4 - $30.54 $5.84 Million - $6.75 Million
221,068 Added 189.69%
337,608 $10.1 Million
Q1 2022

May 16, 2022
BUY
$23.07 - $27.99 $2.69 Million - $3.26 Million
116,540 New
116,540 $3.07 Million
Q4 2021

Feb 14, 2022
SELL
$21.47 - $32.08 $272,669 - $407,416
-12,700 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$23.37 - $32.13 $2.48 Million - $3.41 Million
-106,202 Reduced 89.32%
12,700 $392,000
Q2 2021

Aug 16, 2021
BUY
$18.78 - $25.15 $2.23 Million - $2.99 Million
118,902 New
118,902 $2.92 Million
Q1 2021

May 17, 2021
SELL
$18.21 - $23.2 $4.8 Million - $6.12 Million
-263,582 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$15.39 - $22.1 $4.06 Million - $5.83 Million
263,582 New
263,582 $5.26 Million
Q2 2020

Aug 14, 2020
SELL
$13.31 - $19.41 $328,597 - $479,194
-24,688 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$13.06 - $21.24 $322,425 - $524,373
24,688 New
24,688 $356,000
Q3 2019

Nov 14, 2019
SELL
$19.51 - $24.28 $624,320 - $776,960
-32,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$21.47 - $37.33 $380,469 - $661,524
17,721 Added 124.11%
32,000 $721,000
Q1 2019

May 15, 2019
SELL
$28.4 - $36.49 $108,516 - $139,428
-3,821 Reduced 21.11%
14,279 $521,000
Q4 2018

Feb 14, 2019
BUY
$27.94 - $44.61 $505,714 - $807,441
18,100 New
18,100 $534,000

Others Institutions Holding ALKS

# of Institutions
364
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.19B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email